| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/24/2004 | WO2004052927A1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052840A1 Compounds which modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/24/2004 | WO2004052412A1 Wound dressings comprising vanadate complexed with organic ligands |
| 06/24/2004 | WO2004052384A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata |
| 06/24/2004 | WO2004052381A1 An organic extract of geum japonicum thumb variant and use thereof |
| 06/24/2004 | WO2004052378A1 Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same |
| 06/24/2004 | WO2004052353A2 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 06/24/2004 | WO2004052323A1 Rooting sesame extract and hair cosmetic |
| 06/24/2004 | WO2004043982A3 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 06/24/2004 | WO2004024060A3 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2003099221A3 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003047589A8 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 06/24/2004 | US20040122125 Lactone compounds as novel photoinitiators |
| 06/24/2004 | US20040122109 Preparation for hair and/or scalp |
| 06/24/2004 | US20040122083 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin" |
| 06/24/2004 | US20040122049 heterocyclic derivatives containing N-substituted piperidine ring and an amide or urea group; useful for treating rheumatic arthritis |
| 06/24/2004 | US20040122047 Substituted tetrahydroisoquinolines |
| 06/24/2004 | US20040122044 Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122006 such as 7-[(2-aminophenyl)sulfanyl]-2H-1,4-benzoxazin-3(4H)-one; oxidation/reduction; deblocking/deprotectiing; cardiovascular disorders |
| 06/24/2004 | US20040121981 Administering therapeutically effective amount of a compound which binds to a galectin |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040121027 plant extracts; solvent extraction; freeze drying |
| 06/24/2004 | US20040121019 Particles comprising a biopolymer which is degradable under the effect of an electromagnetic wave as emitted by a solar radiation |
| 06/24/2004 | US20040120970 vaccine is for administration in the submucosa of the labiae is an attenuated form of a horse pathogenic bacterium |
| 06/24/2004 | US20040120918 Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides |
| 06/24/2004 | US20040120917 Cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses |
| 06/24/2004 | DE10256881A1 Neue topische Verwendung von Bis-Arylimidazo[1,2-a]thiolanderivaten New topical use of bis-Arylimidazo [1,2-a] thiolanderivaten |
| 06/24/2004 | CA2526901A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata |
| 06/24/2004 | CA2506732A1 Compounds which modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/24/2004 | CA2505407A1 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1431284A1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 06/23/2004 | EP1431275A1 Diaryl ether derivative, addition salt thereof, and immunosuppressant |
| 06/23/2004 | EP1430933A2 Cosmetic and pharmaceutical compositions comprising steroid sulfatase inhibitors and their use for the reduction of hair loss |
| 06/23/2004 | EP1430905A1 External preparation for the skin |
| 06/23/2004 | EP1430133A2 A soluble toll-like receptor |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430073A1 Solvent extraction process |
| 06/23/2004 | EP1430067A2 Eukaryotic cells and method for preserving cells |
| 06/23/2004 | EP1430057A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives |
| 06/23/2004 | EP1430056A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 06/23/2004 | EP1430053A1 Chemical compounds |
| 06/23/2004 | EP1430051A1 N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamines as antiproliferative compounds |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1430024A1 Alkyl urea retinoid agonists i |
| 06/23/2004 | EP1430023A1 Substituied urea retinoid agonists ii |
| 06/23/2004 | EP1430020A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 06/23/2004 | EP1429799A2 Kgf polypeptide compositions |
| 06/23/2004 | EP1429796A2 Peptide antiangiogenic drugs |
| 06/23/2004 | EP1429792A1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 06/23/2004 | EP1429791A2 Method and topical formulation for treating skin conditions associated with aging |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429782A1 Modulation of vitamin storage |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429778A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429756A2 Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| 06/23/2004 | EP1429752A1 Neuroprotective treatment methods using selective inos inhibitors |
| 06/23/2004 | EP1429723A1 Treating effects of excessive reactive oxygen species |
| 06/23/2004 | EP1429719A1 Anti-inflammatory dermocosmetologic composition in particular for treating acne and seborrheic dermatitis |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1263932A4 Embryonic stem cells and neural progenitor cells derived therefrom |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1251848B1 Gyrase inhibitors and uses thereof |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1032671B1 Mammalian cytokine-like polypeptide-10 |
| 06/23/2004 | EP1009398A4 Molecular complex and control-release of alpha hydroxyacids |
| 06/23/2004 | EP1007045B1 Topical application of opioid analgesic drugs such as morphine |
| 06/23/2004 | EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 06/23/2004 | EP0930886B1 Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
| 06/23/2004 | CN1507450A Novel cyclo azaphospha hydrocarbons |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507339A Use of 3-position cyclosporin derivatives for hair growth |
| 06/23/2004 | CN1506376A Embedded CD25-resisting monoclonal antibody and its coding sequence and application |
| 06/23/2004 | CN1506110A Application of Bulgaria inquinans or its mycelium in preparing medicine |
| 06/23/2004 | CN1506108A Composite milk powder capable of being eaten and made into beautifying face mask |
| 06/23/2004 | CN1506103A Hair follice activating liquid |
| 06/23/2004 | CN1506102A Toxin expelling and face nursing aloe capsule and its making process |
| 06/23/2004 | CN1506101A Medicine composition for treating psoriasis |
| 06/23/2004 | CN1506086A Specific medicine for treating burns and scalds |
| 06/23/2004 | CN1506084A Qubaiding tincture and its prepn |
| 06/23/2004 | CN1506082A Beverage capable of turning white hair into black hair |
| 06/23/2004 | CN1506074A Jiaoqijing medicine for treating beriberi and its prepn |
| 06/23/2004 | CN1506071A High-permeability burn treating prepn |
| 06/23/2004 | CN1506063A Cell growth regulatnig factor F and its prepn process |
| 06/23/2004 | CN1506059A Cell growth regulating factor K and its prepn process |
| 06/23/2004 | CN1506055A Cell growth regulatnig factor S and its prepn process |